These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36001142)

  • 21. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases.
    Guan YZ; Cui LY; Liu MS; Niu JW
    Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generalization after ocular onset in myasthenia gravis: a case series in Germany.
    Li F; Hotter B; Swierzy M; Ismail M; Meisel A; Rückert JC
    J Neurol; 2018 Dec; 265(12):2773-2782. PubMed ID: 30225725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody profile may predict outcome in ocular myasthenia gravis.
    Galassi G; Mazzoli M; Ariatti A; Kaleci S; Valzania F; Nichelli PF
    Acta Neurol Belg; 2018 Sep; 118(3):435-443. PubMed ID: 29858757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?
    Monte G; Spagni G; Damato V; Iorio R; Marino M; Evoli A
    J Neurol; 2021 May; 268(5):1803-1807. PubMed ID: 33387011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of immunosuppression treatment with generalization among patients with ocular myasthenia gravis: A propensity score analysis.
    Ruan Z; Guo R; Zhou H; Gao F; Lin Y; Xu Q; Yu L; Wu S; Lei T; Zhang M; Gao Y; Lu X; Li H; Sun C; Tang B; Li Z; Chang T
    Eur J Neurol; 2022 Jun; 29(6):1805-1814. PubMed ID: 35188698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset.
    Zhao S; Yan X; Ding J; Ren K; Sun S; Lu J; Zhang C; Zhang K; Li Z; Guo J
    Front Neurol; 2022; 13():857402. PubMed ID: 35547386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-30e-5p as predictor of generalization in ocular myasthenia gravis.
    Sabre L; Maddison P; Wong SH; Sadalage G; Ambrose PA; Plant GT; Punga AR
    Ann Clin Transl Neurol; 2019 Feb; 6(2):243-251. PubMed ID: 30847357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes After Transcervical Thymectomy for Ocular Myasthenia Gravis: A Retrospective Cohort Study With Inverse Probability Weighting.
    Hamedani AG; Pistilli M; Singhal S; Shindler KS; Avery RA; Tamhankar MA; Liu GT
    J Neuroophthalmol; 2020 Mar; 40(1):8-14. PubMed ID: 31453917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study.
    Hendricks TM; Bhatti MT; Hodge DO; Chen JJ
    Am J Ophthalmol; 2019 Sep; 205():99-105. PubMed ID: 31077669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of the generalization of myasthenia gravis with purely ocular symptoms at onset: a multivariable model development and validation.
    Li F; Zhang H; Tao Y; Stascheit F; Han J; Gao F; Liu H; Carmona-Bayonas A; Li Z; Rueckert JC; Meisel A; Zhao S
    Ther Adv Neurol Disord; 2022; 15():17562864221104508. PubMed ID: 35755967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental factors affecting the risk of generalization for ocular-onset myasthenia gravis: a nationwide cohort study.
    Wang J; Zhou H; Chen H; Feng H; Chang T; Sun C; Guo R; Ruan Z; Bi F; Li J; Wang J; Wang K; Ma G; Lei S; Wang C; Wang Z; Huang F; Zhang S; Wen Q; Wang Y; Sun Y; Li Y; Xie N; Liu H; Jiang Y; Lei L; Fan Z; Su S; Lu Y; Di L; Xu M; Wang M; Chen H; Wang S; Wen X; Zhu W; Duo J; Huang Y; Zheng D; Da Y
    QJM; 2024 Feb; 117(2):109-118. PubMed ID: 37802883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular myasthenia gravis: updates on an elusive target.
    Melson AT; McClelland CM; Lee MS
    Curr Opin Neurol; 2020 Feb; 33(1):55-61. PubMed ID: 31789705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
    Gratton SM; Herro AM; Feuer WJ; Lam BL
    J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis of Ocular Myasthenia Gravis in an Argentinian Population.
    Aguirre F; Villa AM
    Eur Neurol; 2018; 79(3-4):113-117. PubMed ID: 29428956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular manifestation and generalization after ocular onset in ocular myasthenia gravis: A 5-year analysis.
    Kemchoknatee P; Arepagorn A; Srisombut T
    Asian Pac J Allergy Immunol; 2021 Oct; ():. PubMed ID: 34717528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ocular myasthenia gravis: diagnostic aspects and evolution].
    de Entrambasaguas M; López-Bernabé R; López-Alemany M
    Rev Neurol; 2007 Apr 1-15; 44(7):397-403. PubMed ID: 17420965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular presentation of myasthenia gravis: A natural history cohort.
    Kamarajah SK; Sadalage G; Palmer J; Carley H; Maddison P; Sivaguru A
    Muscle Nerve; 2018 Apr; 57(4):622-627. PubMed ID: 28881457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective study of acetylcholine receptor antibody positive ocular myasthenia in the West of Scotland.
    Farrugia ME; Cleary M; Carmichael C
    J Neurol Sci; 2017 Nov; 382():84-86. PubMed ID: 29111026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
    Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C
    J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.